- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about ALNY
Recent news which mentions ALNY
From Benzinga
7 Potential Biotech Stocks Buyout Targets in 2022
April 21, 2022
From InvestorPlace
Alnylam Pharmaceuticals Q1 2022 Earnings Conference Call On April 28, 2022 At 08:30 AM ET
April 19, 2022
Tickers
ALNY
From Benzinga
7 Biotech Stocks to Buy With Key Catalysts for April
April 05, 2022
From InvestorPlace
From Benzinga
From Motley Fool
Maker Of Pfizer's COVID-19 Vaccine mRNA-Delivery Tech Sues Arbutus Biopharma: Reuters
March 18, 2022
From Benzinga
Alnylam Hits Pfizer, Moderna With Patent Infringement Suits
March 17, 2022
From Benzinga
From Benzinga
Looking Into Alnylam Pharmaceuticals's Return On Capital Employed
February 11, 2022
Tickers
ALNY
From Benzinga
Alnylam Clocks 76% Increase In Q4 Product Sales, Expects FY22 Product Sales Of Up To $1B
February 10, 2022
From Benzinga
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
February 10, 2022
From Benzinga
Earnings Scheduled For February 10, 2022
February 10, 2022
From Benzinga
12 biotech stocks to consider buying now as prospects for the sector brighten this year
February 06, 2022
From MarketWatch
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2022
February 03, 2022
From Benzinga
A Bearish Sign Appears On Alnylam Pharmaceuticals's Chart
January 21, 2022
Tickers
ALNY
From Benzinga
The Daily Biotech Pulse: Kura Lifts Clinical Hold On Blood Cancer Trial, Intuitive Surgical Earnings, Sorrento's Omicron Antibody Treatment Effective
January 21, 2022
From Benzinga
What 10 Analyst Ratings Have To Say About Alnylam Pharmaceuticals
January 20, 2022
Tickers
ALNY
From Benzinga
The Week Ahead In Biotech (Jan 16-22): Focus On Data Presentations And IPOs In Holiday-Shortened Week
January 16, 2022
From Benzinga
3 Can't-Miss Biotech Events Coming Up in 2022
January 07, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 3, 2022
January 03, 2022
From Benzinga
What 9 Analyst Ratings Have To Say About Alnylam Pharmaceuticals
January 03, 2022
Tickers
ALNY
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.